Major clinical research advances in gynecologic cancer in 2022: highlight on late-line PARP inhibitor withdrawal in ovarian cancer, the impact of ARIEL-4, and SOLO-3

In the 2022 series, we summarized the major clinical research advances in gynecologic oncology based on communications at the conference of Asian Society of Gynecologic Oncology Review Course. The review consisted of 1) Ovarian cancer: long-term follow-up data, new poly (ADP-ribose) polymerase (PARP...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Jung-Yun, Lee, Yoo-Young, Park, Jeong-Yeol, Shim, Seung-Hyuk, Kim, Se Ik, Kong, Tae-Wook, Lim, Chul Kwon, Cho, Hyun Woong, Suh, Dong Hoon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology; Japan Society of Gynecologic Oncology 2023
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9995865/
https://www.ncbi.nlm.nih.gov/pubmed/36890294
http://dx.doi.org/10.3802/jgo.2023.34.e51

Ejemplares similares

Ejemplares similares

  • Ariel
    por: Rodó, José Enrique, 1871-1917
    Publicado: (1936)
  • Ariel
    por: Rodó, José Enrique, 1871-1917
    Publicado: (1975)
  • Ariel
    por: Rodó, José Enrique, 1871-1917
    Publicado: (1984)
  • Ariel
    por: Rodó, José Enrique, 1871-1917
    Publicado: (1942)
  • Ariel : Algunos motivos de Proteo
    por: Rodó, José Enrique, 1871-1917
    Publicado: (1976)